Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

RCGP/CPRD Quality Improvement Project

Posted on:

The Royal College of General Practitioners (RCGP) and the MHRA Clinical Practice Research Datalink (CPRD) have developed confidential bespoke practice and patient-level drug prescribing reports, available for free for GP practices contributing to CPRD.

The reports focus on prescribing and patient safety, allowing practices to benchmark themselves against others contributing to CPRD. The reports can be used for appraisal (under Domain 2 – Safety & Quality) and revalidation.

The reports currently include four indicators:

  1. Prescription of NSAIDs to patients with heart failure
  2. Prescription of glitazones to patients with heart failure
  3. Prescription of NSAIDs to patients with chronic kidney disease (CKD)
  4. Aspirin monotherapy for stroke prevention in patients with atrial fibrillation

Additional indicators are being developed for inclusion later in the year. Further information and example reports can be found on the RCGP/CPRD Quality Improvement Project webpage.